Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Accured Expenses (2022 - 2025)

Historic Change in Accured Expenses for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $2.1 million.

  • Gossamer Bio's Change in Accured Expenses rose 16106.98% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 14824.99%. This contributed to the annual value of -$10.7 million for FY2024, which is 3658.72% down from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Change in Accured Expenses is $2.1 million, which was up 16106.98% from $11.0 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Change in Accured Expenses registered a high of $11.0 million during Q2 2025, and its lowest value of -$9.3 million during Q1 2024.
  • Its 4-year average for Change in Accured Expenses is -$862866.7, with a median of -$940000.0 in 2024.
  • As far as peak fluctuations go, Gossamer Bio's Change in Accured Expenses crashed by 51032.86% in 2024, and later surged by 26743.56% in 2025.
  • Quarter analysis of 4 years shows Gossamer Bio's Change in Accured Expenses stood at -$6.2 million in 2022, then soared by 45.74% to -$3.4 million in 2023, then skyrocketed by 72.06% to -$940000.0 in 2024, then soared by 327.13% to $2.1 million in 2025.
  • Its Change in Accured Expenses stands at $2.1 million for Q3 2025, versus $11.0 million for Q2 2025 and -$5.8 million for Q1 2025.